Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma
American Journal of Clinical Pathology · 2026
DOI: 10.1093/ajcp/aqag073 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2026. Verfasst von Shahzan Anjum und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Pathology Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Eye Neoplasms, Lacrimal Apparatus Diseases, Proto-Oncogene Proteins c-myb. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objectives
Lacrimal gland adenoid cystic carcinoma (ACC) is a rare and lethal malignancy associated with a poor prognosis, with no known therapeutic targets. The clinical relevance of Myb, Sox4, c-Kit protein expression, and the MYB::NFIB fusion gene in lacrimal gland ACC is not well known. The current study aims to investigate the prognostic significance of Myb, Sox-4, c-Kit protein, and the MYB::NFIB fusion gene in lacrimal gland ACC.
Methods
A total of 30 histopathologically diagnosed lacrimal gland ACC cases were included in this study. Myb, Sox4, c-Kit expression, and MYB::NFIB gene fusion were evaluated by immunohistochemistry and fluorescence in situ hybridization, respectively. The results were correlated with clinicopathologic features and patient survival.
Results
Immunoexpression of Myb, Sox4, and c-Kit was observed in 70%, 63%, and 63% of ACC cases, respectively. Myb expression showed a significant association with the solid and cribriform histologic patterns, Sox-4 expression, and disease-free survival. On univariate analysis, Myb expression, solid histologic pattern, bone erosion, intracranial extension, and advanced tumor stage were indicators of poor prognosis. c-Kit expression showed a significant association with advanced tumor stage. MYB::NFIB fusion, detected in 47% of cases, was significantly associated with intracranial extension.
Conclusions
Myb protein emerged as a prognostic indicator in the pathogenesis and clinical outcomes of patients with lacrimal gland ACC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ocular Pathology Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Medical Oncology, Dr. Bhim Rao Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
- Department of Ophthalmology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Zitieren
APA
Anjum, S., Sen, S., Sharma, M. C., Bakhshi, S., Chosdol, K., Kashyap, S., Pushker, N., Bajaj, M. S., & Meel, R. (2026). Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqag073
Vancouver
Anjum S, Sen S, Sharma MC, Bakhshi S, Chosdol K, Kashyap S, et al. Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma. American Journal of Clinical Pathology. 2026. doi:10.1093/ajcp/aqag073
BibTeX
@article{Anjum2026,
author = {Anjum, Shahzan and Sen, Seema and Sharma, Mehar C and Bakhshi, Sameer and Chosdol, Kunzang and Kashyap, Seema and Pushker, Neelam and Bajaj, Mandeep S and Meel, Rachna},
title = {Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma},
journal = {American Journal of Clinical Pathology},
year = {2026},
doi = {10.1093/ajcp/aqag073}
}
EUVIMED